Exploring Oligonucleotide Therapeutics for CNS Repeat Expansion Disorders: Spotlight on Huntington’s Disease
Time: 9:30 am
day: Day Two
Details:
- Key highlights from progress within our ASO approach against Huntington’s Disease
- Lessons learned from our work to improve our drug development strategy moving forwards
- Illustrating distribution across the brain in pre-clinical models
